Helper proteins for neuroendocrine secretion
The granins, known to be general constituents of neuroendocrine secretory granules, are regulators of the proteolytic processing of peptide precursors and promote their aggregation-mediated sorting into secretory granules.
Eukaryotic cells capable of regulated protein secretionthe exocytotic release of proteins in response to a stimulus -package some of their secretory proteins into specific storage organelles, the secretory granules. In doing so, these cells sort secretory proteins away from others that are delivered to the cell surface via the constitutive secretory pathway common to all eukaryotic cells ( Fig. 1 ) [1] . The selective aggregation/condensation of 'regulated', but not of 'constitutive', secretory proteins is thought to be of crucial importance for this sorting process in all types of regulated secretory cell [2] . Another characteristic of the regulated secretory pathway -the generation of biologically active peptides by specific proteolytic processing of inactive precursors at sites usually characterized by basic amino acids -is found only in certain types of regulated secretory cell, primarily endocrine cells and neurons, referred to collectively as neuroendocrine cells (reviewed recently in [3] ).
The proteolytic processing of newly synthesized peptide precursors does not usually start before they reach the last subcompartment of the Golgi complex, the trans-Golgi network, where the constitutive and regulated pathways begin to diverge. But both the peptide precursors and the endoproteases concerned are synthesized in the rough endoplasmic reticulum (ER), and they travel together to, and through, the Golgi complex into secretory granules. How, then, do neuroendocrine cells prevent premature cleavage of peptide precursors in the proximal compartments of the secretory pathway? And, given that cleavage of peptide precursors at certain sites does occur in the trans-Golgi network (for example, see [4] ), how do neuroendocrine cells ensure that the resulting precursor fragments, or at least the relevant ones, nevertheless participate in aggregation/condensationmediated sorting into secretory granules? In answer to these two questions, recent evidence shows that members of (or proteins related to) the granin family function as helper proteins in the regulation of proteolytic processing and in sorting.
The granins -a family of neuroendocrine-specific proteins in search of a function The granins (also known as chromogranins/secretogranins) are a family of acidic, heat-stable, secretory proteins of unresolved function that have long been known to be widespread constituents of secretory granules in neuroendocrine cells (see [5] and references therein). In addition to the three classical granins, chromogranin A, chromogranin B (secretogranin I) and secretogranin II, other proteins have been proposed to belong to this family, in particular 7B2 (secretogranin V) [5] . All these proteins contain several pairs of basic amino-acid residues and are cleaved intracellularly at some of these dibasic sites before secretion. This observation has been taken as indicating the possibility that the granins themselves may be precursors of bioactive peptides (see [6] and references therein).
Although peptide fragments derived from chromogranin A (such as pancreastatin) and from secretogranin II (secretoneurin) apparently exhibit some activity as autocrine or paracrine regulators of secretion (see [6] and references therein), most granin researchers suspect that these effects reflect, at best, only one of the functions of the granins [5] . Indeed, ever since the observation that chromogranin A, chromogranin B and secretogranin II have common properties led to the concept of the granins as a family [7] , it has been proposed that they may function intracellularly in the regulated secretory pathway, for example as helper proteins in the sorting of peptide precursors [7] or as inhibitors of precursor processing [8] . Recent observations by Martens and coworkers [9, 10] now establish a role for 7B2 in the control of precursor processing.
7B2 prevents premature activation of the prohormone convertase PC2
The 7B2 protein, discovered by Chr6tien, Seidah and colleagues [11] , is synthesized as an approximately 27 kilodalton (kD) polypeptide (referred to here as uncleaved 7B2) and is then proteolytically processed in the cell into an amino-terminal 21 kD form (referred to as cleaved 7B2; see references in [9, 10, 12] ). (We prefer not to use the terms 7B2 precursor or pro-7B2 for the uncleaved form, as this may give rise to the misconception that cleaved 7B2 is the biologically relevant form of the protein.) 7B2 has a widespread distribution in neuroendocrine cells that is very similar, if not identical, to that of PC2, one of the pro-hormone/pro-neuropeptideconverting endoproteases that are related to the bacterial protease, subtilisin, and the yeast endoprotease, kex-2, and that cleave precursors at dibasic sites [13, 14] . Moreover, the expression of 7B2 and that of PC2 are coordinately regulated.
An important clue that these correlations of expression are not just coincidental came with the demonstration that recombinant 7B2 inhibits the endoprotease activity of PC2 in vitro [9] . In searching for the physiological
confirmed that a complex forms between 7B2 and PC2, extended these observations by showing that 7B2 also does not bind to furin, PACE4 and PC5, three other members of the subtilisin/kex-2-related endoprotease family. Third, the association between 7B2 and PC2 is between uncleaved 7B2 and the 75 kD inactive 'pro' form of PC2, and seems to begin in the rough ER. Finally, this association is lost concomitantly with the processing of uncleaved 7B2 to the carboxy-terminally truncated cleaved 7B2 (18 kD in Xenopus) and the conversion of proPC2 to the active 69 kD enzyme (Fig. 1) .
What is required for this liaison between 7B2 and the PC2 endoprotease to occur? Where exactly in the secretory pathway does it end? And what triggers the divorce?
The amino-terminal portion of 7B2 has some homology to the chaperonins [10] , the molecular "chaperones that help proteins to fold" [15] . Perhaps this domain of 7B2 contributes to its association with pro-PC2, along with the cluster of basic amino-acid residues at the cleavage site of 7B2 that also seem to be critical for binding to PC2 [12] . Furthermore, experiments with thapsigargin, an inhibitor of the Ca 2 + pump of the ER, suggest that the Ca 2 +-rich milieu of this compartment is somehow important for formation of the complex [12] . relevance of this inhibition, Martens and colleagues [10] , working with Xenopus intermediate pituitary gland, recently reported the following intriguing observations. First, 7B2 forms a physical complex with the PC2 protease in vivo. Second, the formation of this complex is specific for PC2: 7B2 does not bind to the related endoprotease PC1/PC3, nor does it inhibit its activity in vitro [9] . Seidah, Chr6tien and colleagues [12] , who
As for the site of dissociation of the complex, labelling of neuroendocrine AtT-20 cells with radioactive sulphate, which is incorporated into proteins in the trans-Golgi network [16] , reveals only uncleaved 7B2, but not cleaved 7B2, after a 10 minute pulse, indicating that cleavage of 7B2 does not occur before the newly synthesized protein reaches the trans-Golgi network [17] . Cleavage of a proportion of the labelled 7B2 molecules was observed after a 15 minute sulphate pulse [17] . As sulphated proteins are known to begin leaving the transGolgi network after 5 minutes of labelling, and they do so with a half-time of around 5 minutes [18] , it follows that (unless the exit of 7B2 from the trans-Golgi network is unusually slow) cleavage of 7B2 occurs soon after the protein leaves the trans-Golgi network -in immature secretory granules, rather than in the transGolgi network itself (Fig. 1 ). This conclusion has also been reached by Zhou and Mains [19] . Similar sulphate-labelling data have been reported for the endoprotease PC2 -only proPC2 but not PC2 itself is labelled after a 15 minute pulse [20] . Hence, the immature secretory granule seems to be the main compartment where uncleaved 7B2 and pro-PC2 are cleaved, and, as these cleavages coincide with dissociation of the two proteins from each other [10] (which in the case of PC2 is followed by activation), the immature granule is also the site where active PC2 is liberated from 7B2 in order to process peptide precursors (Fig. 1). (Even if the available data were to reflect cleavage of 7B2 and activation of PC2 in the trans-Golgi network, these events would take place so shortly before the exit of active PC2 from the trans-Golgi network that the main compartment for PC2 action would nonetheless be the immature secretory granule.) Dissociation of the 7B2-PC2 complex may be triggered by the cleavage of 7B2, a process thought to be catalyzed by furin or the furin-like..endoprotease, PACE4 [17] . Furin is expressed in constitutive as well as in regulated secretory cells and, in the course of its passage from the trans-Golgi network to the plasma membrane and back [21] , it may well utilize not only the constitutive, but also the constitutive-like, pathway (Fig. 1) ; it will thus pass through immature secretory granules.
The proteolytic processing of a given peptide hormone or neuropeptide precursor at its various cleavage sites has been known to occur in a strict temporal order, starting (for some precursors) in the trans-Golgi network and continuing in immature (and sometimes mature) secretory granules (see below) [3, 19] . Of the two major endoproteases mediating this processing [13, 14] , PC2 is activated later in the secretory pathway than PC1/PC3 [19, 20] . The reason for this delayed activation, which is one important parameter in the temporal control of precursor processing, was unknown. The observations of Martens and colleagues [10] offer an explanation, as they suggest that the association of uncleaved 7B2 with proPC2 in the rough ER provides a safeguard mechanism to prevent premature activation of the PC2 endoprotease in the secretory pathway. Starting from the definition that a molecular chaperone "binds to and stabilizes an other-. wise unstable conformer of another protein and by controlled binding and release of the substrate protein facilitates its switching between active/inactive conformations" [15] , Martens and colleagues [10] propose that 7B2, presumably through its amino-terminal domain, exerts a chaperone-like action on pro-PC2 by "holding it in an inactive form" during transport from the ER to the trans-Golgi network (Fig. 1) . This is an interesting hypothesis which, however, requires additional work and perhaps further definition of terms.
If uncleaved 7B2 were absent, PC2 activation, which is thought to occur by autocatalytic cleavage [22] , could occur prematurely -for example, early in the transGolgi network, where the milieu of low pH/high Ca 2 +
[2] might already be permissive for self-activation of PC2. In addition, the ability of uncleaved 7B2 to inhibit PC2 activity, presumably through its carboxy-terminal domain [9] , might also be relevant in this context. Switching off this protective mechanism via cleavage of 7B2 by an endoprotease (furin or PACE4) that acts, at the earliest, very late in the trans-Golgi network, represents a clever way of timing the activation of PC2 to the appropriate compartment, namely the immature secretory granule (Fig. 1) .
Controlled activation of endoproteases, however, is not the only task that neuroendocrine cells need to perform in order to release properly processed peptides from secretory granules. Another is to ensure that precursor fragments generated in the trans-Golgi network by endoproteases such as furin or PC1/PC3 are actually sorted into immature secretory granules. As it turns out, another member of the granin family, chromogranin B [5] , seems to operate in this process. Before briefly summarizing these data, however, we should first consider the two levels at which sorting of proteins into the regulated secretory pathway occurs in neuroendocrine cells.
The regulated secretory pathway has two levels of sorting
The first level of sorting takes place in the trans-Golgi network, where regulated secretory proteins segregate from constitutive secretory proteins by selective aggregation (Fig. 1) [2] . This process, which gives rise to the dense cores observed in the trans-Golgi network by electron microscopy, is thought to reflect the intrinsic tendency of regulated -but not constitutive -secretory proteins to self-associate upon reaching a critical concentration and encountering the specific lumenal milieu of the trans-Golgi network. The aggregates of regulated secretory proteins are believed to interact, via defined short sequences, with membrane components in the trans-Golgi network -the postulated sorting receptors; they are then enveloped by membrane, thereby extruding most of the fluid phase containing constitutive secretory proteins, and pinch off from the trans-Golgi network to form immature secretory granules [2] .
The second level of sorting occurs in the course of maturation of immature secretory granules (Fig. 1) . This process involves the further condensation of the secretory granule matrix and removal of excess membrane, and may be accompanied by the fusion of several immature secretory granules with each other [23] [24] [25] . During maturation of the immature secretory granule, membrane components such as sorting receptors are thought to be removed via clathrin-coated, immature granule-derived vesicles; this would have the beneficial side-effect that proteins that do not remain with, or never were part of, the aggregated/condensed secretory granule matrix would also be removed. Such proteins include residual constitutive secretory proteins and unwanted protein fragments resulting from the proteolytic processing of precursors (for example, the C-peptide of pro-insulin), which then undergo constitutive-like secretion (Fig. 1) [24, 25] .
Chromogranin B promotes sorting of precursor fragments to secretory granules The multipeptide precursor pro-opiomelanocortin is an example of a regulated secretory protein that undergoes, firstly, proteolytic processing in a strict temporal order, and, secondly, sorting at the levels of both the transGolgi network and the immature secretory granule (see [19] and references therein). In AtT-20 neuroendocrine cells, pro-opiomelanocortin is cleaved in the trans-Golgi network at the dibasic site corresponding to the carboxyl terminus of adrenocorticotropin (ACTH), yielding an amino-terminal 23 kD fragment (containing ACTH) and the carboxy-terminal -lipotropin (-LPH) fragment. This is followed by cleavage, in immature granules, of the 23 kD fragment at the dibasic site corresponding to the amino terminus of ACTH, yielding an amino-terminal 16 kD fragment and ACTH itself (Fig. 1) .
In AtT-20 cells, packaging of the 23 kD fragment in the trans-Golgi network into immature secretory granules operates with only partial efficiency, so that a significant proportion is secreted constitutively. We have exploited this property to investigate a possible role of chromogranin B in peptide-precursor sorting. Overexpression of chromogranin B doubles the efficiency with which the 23 kD fragment is sorted to immature secretory granules and subsequently processed to ACTH, and it reduces the constitutive-like secretion of the 16 kD fragment from immature secretory granules (our unpublished observations) (Fig. 1) . As in the case of 7B2 binding to the PC2 endoprotease, chromogranin B overexpression shows target specificity: the exit of -LPH from the trans-Golgi network, which in AtT-20 cells is largely packaged into constitutive secretory vesicles, is unaffected. We conclude that chromogranin B functions as a helper protein in the sorting of certain peptide precursor fragments to the regulated secretory pathway.
Perspectives
How do peptide hormones and neuropeptides, which are initially synthesized as parts of larger biologically inactive precursors, end up properly processed in the secretory granules of neuroendocrine cells? A few years ago, this question was dominated by the characterization of the relevant processing enzymes and by efforts to elucidate the basic mechanisms underlying sorting to the regulated pathway. Meanwhile, additional players, long known to be part of the ensemble, have appeared on stage, and we are beginning to understand their roles as helper proteins in the sorting and processing events. But the complexity of peptide-precursor handling by neuroendocrine cells makes it a safe guess that we do not yet know the entire cast.
